Powerful new competition from (fill in blank), who is actively promoting their new color label printer, the is the first in their ColorWorks division. Quality company offering this printer at cut-rate prices. Time to squeeze the high-priced Quicklabel market. triple w. packagingdigest dot com slash labels slash-tabletop hyphen printer hyphen capableof hyphen printing hyphen printing hyphen 60k hyphen labels hyphen daily 140915
Sentiment: Strong Sell
Good luck with that...Why would you sell at $5.20-5.40 if you plan on re-buying shares tomorrow at $5.87?
Maybe you meant $4.87?
Then why are they not buying today, and telling their clients about it?
He's got no money, he's just a pay for hire journalist. He'll slant the piece any way you like for the right price.
They just approved time release hydrocodone, Zydone, and all of the politician and states people are up in arms about it. There are more than enough painkillers in the marketplace, and this is another easy one to abuse. The FDA does not always make the "best" decision.
Exact same drug as Buprion. Zyban is the identical drug. He wants you to quite smoking.
And it's still down 4-1/2 hours later? The tutes were selling into it in a big way this morning, not on a miscommunication. Do you buy or sell anything on news if you don't know what the news is?
Yes, but this is only if Fartstain is telling the truth, which he has a problem doing sometimes.
The market cap for Arena is $883 Million. That's a far cry from $2.1B! Already, Fartstain is showing his ignorance, as Vivus' market cap is $419M. So Orex is already valued more highly than Vivus. Those other numbers are from around a year ago and are meaningless now.
Good question. This stock had its run from 3 to 6, and it wont' get any better until they deliver some respectable sales and earnings. I would not hold this stock at this point in time. What they have is a mixed generic product, which now may have to be reviewed by the FDA for scheduling. Naltrexone is made with Thebaine, which is super-powerful opiate from which all others are derived. That is how it keeps drug addicts from seeking street drugs. It was schedule II in the 1970s.
That can be the kick-back when a company tries to simply market a blend of 2 generics, instead of coming out with a novel, new chemical entity.
Cramer's flunky wrote: "Still, it's hard to ignore the potential value in Best Buy shares and the company could become 2015's best turnaround candidate in retail."
How many turnarounds can one company have???
Especially ones from the ghetto, where they really need to make some money! Spread the word amongst your friends.
$8 is much better, time to plunge in before the inevitable bounce back up. I'll be there with a wad of cash on Tuesday morning!
Back to the 12s AFTER the second quarter release, which they thought was good! It missed the estimate, so we'll flounder around for at least another 3 months in the 11s and 12s. Operations were not so excellent. Meanwhile the NASDAQ hits 5 year highs.
Sentiment: Strong Sell
Back to where we were after yesterday's little pop, which was unjustified anyhow. We missed the earnings expectation of 23 cents by 6 cents. Where is Sharon, this thing is lifeless. I forgot it's just RI investors, a very high percentage of the US population.